Scott Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Scott Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$813K	Hold	14,000	–	–	1.87%	32
2023 Q2	$895K	Hold	14,000	–	–	2.01%	27
2023 Q1	$970K	Hold	14,000	–	–	2.24%	21
2022 Q4	$1.01M	Hold	14,000	–	–	2.43%	17
2022 Q3	$995K	Hold	14,000	–	–	2.67%	10
2022 Q2	$1.08M	Hold	14,000	–	–	0.72%	30
2022 Q1	$1.02M	Hold	14,000	–	–	0.62%	30
2021 Q4	$873K	Hold	14,000	–	–	0.55%	34
2021 Q3	$828K	Hold	14,000	–	–	0.57%	34
2021 Q2	$935K	Hold	14,000	–	–	0.66%	33
2021 Q1	$884K	Buy	+14,000	New	+$871K	0.65%	31

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Scott Investment Partners's BMY Position: Q3 2023 in Review

Scott Investment Partners held its Bristol-Myers Squibb (BMY) position steady in Q3 2023 at 14,000 shares worth $813K. The position accounts for 1.87% of the portfolio, ranked #32.

Scott Investment Partners first reported a position in BMY in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.08M in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Scott Investment Partners held 14,000 shares of Bristol-Myers Squibb worth $813K as of Q3 2023.
Scott Investment Partners left its Bristol-Myers Squibb share count unchanged in Q3 2023.
Bristol-Myers Squibb made up 1.87% of Scott Investment Partners's portfolio in Q3 2023, its #32 holding.
Scott Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 11 quarters since.
Scott Investment Partners's Bristol-Myers Squibb position peaked at $1.08M in Q2 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Scott Investment Partners's 13F filing for Q3 2023, filed 1 Nov 2023.